5mg dispense of Eureca-V Nuclease. CRISPR protein, Eureca-V™ Nuclease is the most recent addition to our catalog. It is based on the proprietary MAD7 nuclease developed by Inscripta. Aldevron and Inscripta have partnered to make this protein broadly available to the therapeutic, diagnostic, and agricultural research markets.Eureca-V is categorized as a Class 2, Type V CRISPR-Cas nuclease. It shares key features common to this family of CRISPR nucleases, including:
•Targets broad array of T-rich PAM domains (YTTV preferred, TTTN functions)
•Requires a single crRNA to cut target DNA sequence
•Staggered double-strand break at cut site creates 5’ overhangs
This product is subject to the following: Limited Use Label License